GADL1
Acidic amino acid decarboxylase GADL1
Also known as: GADL1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6ZQY3
- Gene
- GADL1
- Ensembl
- ENSG00000144644
- Chromosome
- 3
- Canonical length
- 521 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Predicted to enable carboxy-lyase activity. Predicted to be involved in carboxylic acid metabolic process. Predicted to be located in cytosol. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
521 residues, UniProt reviewed canonical sequence.
>Q6ZQY3|GADL1
1 MSSDSDRQCP VDGDIDQQEM IPSKKNAVLV DGVVLNGPTT DAKAGEKFVE EACRLIMEEV
61 VLKATDVNEK VCEWRPPEQL KQLLDLEMRD SGEPPHKLLE LCRDVIHYSV KTNHPRFFNQ
121 LYAGLDYYSL VARFMTEALN PSVYTYEVSP VFLLVEEAVL KKMIEFIGWK EGDGIFNPGG
181 SVSNMYAMNL ARYKYCPDIK EKGLSGSPRL ILFTSAECHY SMKKAASFLG IGTENVCFVE
241 TDGRGKMIPE ELEKQVWQAR KEGAAPFLVC ATSGTTVLGA FDPLDEIADI CERHSLWLHV
301 DASWGGSALM SRKHRKLLHG IHRADSVAWN PHKMLMAGIQ CCALLVKDKS DLLKKCYSAK
361 ASYLFQQDKF YDVSYDTGDK SIQCSRRPDA FKFWMTWKAL GTLGLEERVN RALALSRYLV
421 DEIKKREGFK LLMEPEYANI CFWYIPPSLR EMEEGPEFWA KLNLVAPAIK ERMMKKGSLM
481 LGYQPHRGKV NFFRQVVISP QVSREDMDFL LDEIDLLGKD MLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GADL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 25 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 25 nTPM
- tongue: 11 nTPM
- retina: 1.4 nTPM
- bone marrow: 1.1 nTPM
- thyroid gland: 0.8 nTPM
- kidney: 0.7 nTPM
Single-cell type
- myonuclei: 152 nCPM
- mesothelial cells: 36 nCPM
- epicardial cells: 32 nCPM
- oocytes: 23 nCPM
- thymic myoid cells: 16 nCPM
- somatotrophs: 15 nCPM
Immune cell
- basophil: 0.2 nTPM
- neutrophil: 0.2 nTPM
- eosinophil: 0.1 nTPM
- gdT-cell: 0.1 nTPM
- memory B-cell: 0.1 nTPM
- naive B-cell: 0.1 nTPM
Brain region
- cerebellum: 20 nTPM
- cerebral cortex: 19 nTPM
- basal ganglia: 19 nTPM
- white matter: 18 nTPM
- amygdala: 18 nTPM
- hippocampal formation: 17 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.43
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.72
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- aspartate 1-decarboxylase activity
- carboxy-lyase activity
- pyridoxal phosphate binding
- sulfinoalanine decarboxylase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GADL1 as an antibody target. Whether an autoantibody or antibody against GADL1 could matter depends on whether native GADL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GADL1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GADL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...